Clinical trial
The Effect of the Consumption of 4 Botanical Extracts (Acerola, Panax Ginseng, Echinacea, Quillaja) on the Innate and Adaptive Immune Response in Healthy Adults: a Pilot Randomized Placebo-controlled Clinical Trial
NCT05117385 is registered in ClinicalTrials.gov with Givaudan France Naturals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of the Consumption of 4 Botanical Extracts (Acerola, Panax Ginseng, Echinacea, Quillaja) on the Innate and Adaptive Immune Response in Healthy Adults: a Pilot Randomized Placebo-controlled Clinical Trial
- Lead sponsor
- Givaudan France Naturals
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 22, 2021
- Completion date
- July 18, 2022
- Enrollment
- 115 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy subject, immunity